Skip to main content
. 2021 Jun 9;9:e11528. doi: 10.7717/peerj.11528

Figure 7. Receiver operating characteristic (ROC) curve analysis of miRNA-30a level to distinguish between stages I–IIA adenocarcinoma and benign lung diseases.

Figure 7

The area under the curve for miRNA-30a was 0.875 (95% confidence interval: 0.790–0.960, p < 0.001).